World health officials are offering hope that the ebbing of the omicron wave could give way to a new, more manageable phase of the COVID-19 pandemic.
The CDC’s director, Dr. Rochelle Walensky, will weigh the panel's advice before making a final decision soon.
The US Food and Drug Administration said Tuesday that quick antigen tests people take at home may be less sensitive to picking up the Omicron variant of the coronavirus, but health officials say they're still a useful tool.
Finally, the U.S. Food and Drug Administration made the long overdue decision this month to drop the requirement that abortion-inducing medica…
The FDA is investigating a multistate outbreak of listeria infections tied to packaged salads from Fresh Express, which announced a product recall.
An experimental COVID-19 drug that could soon become the first U.S.-authorized pill to treat the coronavirus faces one final hurdle Tuesday: A panel of government experts.
The CDC is advising consumers to avoid purchasing certain onions due to a salmonella outbreak reported in 38 states and Puerto Rico.
Actor Matthew McConaughey reveals he doesn't agree with COVID-19 vaccine mandates for children but has had his own jab.
Older Americans and other groups particularly vulnerable to the virus have had access to a third dose of the Pfizer and BioNTech vaccine since September.
Anticipating a green light from vaccine advisers, the Biden administration is assembling and shipping millions of COVID-19 shots for children ages 5-11.
The FDA cleared kid-size doses — just a third of the amount given to teens and adults — for emergency use, and up to 28 million more American children could be eligible for vaccinations as early as next week.
U.S. regulators signed off on extending COVID-19 boosters to Americans who got the Moderna or Johnson & Johnson vaccines and said anyone eligible for an extra dose can get a brand different from the one they received initially.
The U.S. moved a step closer Wednesday to offering booster doses of Pfizer's COVID-19 vaccine to senior citizens and others at high risk from the virus as the FDA signed off on the targeted use of the extra shots.
A federal advisory panel endorsed a plan to give Pfizer booster shots against COVID-19 to those who are 65 or older or run a risk of severe disease after rejecting a plan to give extra shots to most Americans.
The U.S. has reached another grim COVID-19 milestone: 1 in 500 Americans have died from the virus. Track the latest numbers here.
If the Food and Drug Administration continues on its current path, a COVID-19 vaccine for children under 12 probably won’t be available until …
Last week, the number of Covid-19 cases in children in the US reached levels not seen since the winter surge. And with the return to school, t…
Also on Monday, the Food and Drug Administration granted full authorization to Pfizer-BioNTech for its vaccine against COVID-19.
While emergency use authorization gets vaccines out to the public more quickly, it doesn’t skip any steps that full approval requires.
With an alarming rise in Covid-19 cases and hospitalizations, more Americans have recently made the decision to get vaccinated than in the las…
The drug is similar to a $56,000-a-year one approved this month that raised hope and stirred controversy.
The FDA has agreed to let adolescents between the ages of 12 and 15 receive the Pfizer COVID-19 vaccine, making it the first available for use in children under 16.